CervoMed Inc. (CRVO) › Cash & EquivalentsCervoMed Inc. (CRVO) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2011-12-31: $98.4K2012-12-31: $312.1K2013-12-31: $255.0K2014-12-31: $2.34M2015-12-31: $2.00M2016-12-31: $1.55M2017-12-31: $8.90M2018-12-31: $7.99M2019-12-31: $14.18M2020-12-31: $18.52M2021-12-31: $37.31M2022-12-31: $4.09M2023-12-31: $7.79M2024-12-31: $9.00M2025-12-31: $8.24M$8.24M2011-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$8.24M-8.5%2026-03-13Balance as of period end2024-12-31$9.00M+15.5%2026-03-13Balance as of period end2023-12-31$7.79M+90.4%2025-03-17Balance as of period end2022-12-31$4.09M-89.0%2024-03-29Balance as of period end2021-12-31$37.31M+101.5%2023-03-24Balance as of period end2020-12-31$18.52M+30.6%2022-03-18Balance as of period end2019-12-31$14.18M+77.4%2021-03-17Balance as of period end2018-12-31$7.99M-10.2%2020-03-17Balance as of period end2017-12-31$8.90M+472.9%2020-03-17Balance as of period end2016-12-31$1.55M-22.2%2019-03-19Balance as of period end2015-12-31$2.00M-14.5%2018-04-02Balance as of period end2014-12-31$2.34M+816.4%2017-03-31Balance as of period end2013-12-31$255.0K-18.3%2016-03-25Balance as of period end2012-12-31$312.1K+217.0%2015-04-03Balance as of period end2011-12-31$98.4K—2014-04-23Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)